लोड हो रहा है...
Predictors of consent to pharmacogenomics testing in the IDEAL study
Pharmacogenomic (PG) testing is important in developing individualized therapeutic approaches. In the phase 3 IDEAL clinical trial, a subset of patients receiving peginterferon and ribavirin for treatment of chronic hepatitis C agreed to provide blood samples for genetic testing. Genome-wide associa...
में बचाया:
| मुख्य लेखकों: | , , , , , , , , , , |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2013
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3951733/ https://ncbi.nlm.nih.gov/pubmed/24061202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0000000000000002 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|